NeuroOne Medical Technologies Corporation
NMTC
$0.7716
-$0.009-1.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.63M | 5.76M | 5.75M | 3.45M | 3.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.63M | 5.76M | 5.75M | 3.45M | 3.92M |
| Cost of Revenue | 6.40M | 6.17M | 6.57M | 6.24M | 7.32M |
| Gross Profit | 230.90K | -414.20K | -816.60K | -2.79M | -3.40M |
| SG&A Expenses | 7.45M | 7.71M | 7.77M | 7.90M | 7.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.00M | -3.00M | -3.00M | -- | -- |
| Total Operating Expenses | 12.30M | 12.34M | 12.54M | 15.34M | 16.16M |
| Operating Income | -5.67M | -6.58M | -6.79M | -11.89M | -12.24M |
| Income Before Tax | -5.34M | -6.60M | -7.19M | -12.32M | -12.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.34 | -6.60 | -7.19 | -12.32 | -12.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.34M | -6.60M | -7.19M | -12.32M | -12.10M |
| EBIT | -5.67M | -6.58M | -6.79M | -11.89M | -12.24M |
| EBITDA | -5.41M | -6.32M | -6.53M | -11.64M | -11.99M |
| EPS Basic | -0.16 | -0.23 | -0.27 | -0.46 | -0.49 |
| Normalized Basic EPS | -0.11 | -0.15 | -0.17 | -0.29 | -0.31 |
| EPS Diluted | -0.16 | -0.23 | -0.27 | -0.46 | -0.49 |
| Normalized Diluted EPS | -0.11 | -0.15 | -0.17 | -0.29 | -0.31 |
| Average Basic Shares Outstanding | 140.36M | 119.11M | 113.91M | 107.07M | 99.52M |
| Average Diluted Shares Outstanding | 140.41M | 119.16M | 113.95M | 107.07M | 99.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |